Stimulation of human polymorphonuclear leukocytes potentiates the uptake of diclofenac and the inhibition of chemotaxis

This publication has 35 references indexed in Scilit:

• Pitfalls in Testing Drug Uptake by Leukocytes Using Radiolabeled Drugs and an Explanation of Conflicting Results with Clindamycin1
  Chemotherapy, 1989
• Volume changes in activated human neutrophils: The role of Na⁺/H⁺ exchange
  Journal of Cellular Physiology, 1986
• In vivo effects of indomethacin and flurbiprofen on the locomotion of neutrophils elicited by immune and non-immune inflammation in the rat
  European Journal of Pharmacology, 1984
• Antibiotic entry into human polymorphonuclear leukocytes
  Antimicrobial Agents and Chemotherapy, 1982
• Effect of indomethacin on the binding of the chemotactic peptide formyl‐Met—Leu—Phe on human polymorphonuclear leukocytes
  FEBS Letters, 1981
• Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
  Journal of Clinical Investigation, 1980
• Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the hypaque-ficoll method
  Journal of Immunological Methods, 1980
• Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis
  Experimental Cell Research, 1972
• Killing of Intraleukocytie Staphylococcus aureus by Rifampin: In-Vitro and In-Vivo Studies
  The Journal of Infectious Diseases, 1972
• THE RELATIONSHIP OF THE CHEMOTACTIC BEHAVIOR OF THE COMPLEMENT-DERIVED FACTORS, C3a, C5a, AND C567, AND A BACTERIAL CHEMOTACTIC FACTOR TO THEIR ABILITY TO ACTIVATE THE PROESTERASE 1 OF RABBIT POLYMORPHONUCLEAR LEUKOCYTES
  The Journal of Experimental Medicine, 1972